학술논문
Deucravacitinib, a selective, allosteric tyrosine kinase 2 inhibitor, in scalp psoriasis: A subset analysis of two phase 3 randomized trials in plaque psoriasis
Document Type
Article
Author
Source
In Journal of the American Academy of Dermatology April 2024 90(4):775-782
Subject
Language
ISSN
0190-9622